RSNA 2025 highlighted a crowded AI landscape—but also the growing complexity of multi-site imaging trials. Learn why scanner variability, protocol...
Boston, MA, March 29, 2023— QMENTA, Inc. announced today that John E. Kelly III, PhD has been appointed to the company's Board of Advisors. Dr. Kelly...
It is difficult to diagnose Parkinson’s disease, and the only way to confirm diagnosis is postmortem. The new imaging AI tools could be the answer.
In order to assure that QMENTA is a reliable trusted partner for managing your medical data, we follow the highest security standards.
Boston, MA, 29/11/21 QMENTA announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for its QMENTA Platform for...
The importance of Data Protection and Data Integrity in Imaging Clinical Trials
QMENTA Launches World Leading Neurology Catalog and Marketplace of AI Imaging Biomarker Analysis Catalog for Medical Imaging Analyses
Diffusion MRI (dMRI) is a vital imaging technique that provides great insight into the brain microstructure. These microstructural properties of the...
There has been a massive acceleration of digitally driven innovation in our lives as of late and the life sciences industry is of course no exception.